Background: Integrin signaling, stimulated by cell adhesion to the extracellular matrix, plays a critical role in coordinating changes in cell morphology and migration. The requisite remodeling of the cytoskeleton is controlled by the Rho family of small GTPases, which are, in turn, regulated via activation by guanine-nucleotide exchange factors (GEFs) and inactivation by GTPaseactivating proteins (GAPs). However, the mechanisms contributing to the precise spatial and temporal regulation of these Rho GTPase modulators remain poorly understood. Results: The Cdc42/Rac GAP CdGAP has previously been implicated as an inhibitor of growth-factor-induced lamellipodia formation. Herein, CdGAP is shown to localize to focal adhesions, potentially through its direct association with the amino terminus of actopaxin, a paxillin and actin binding protein. CdGAP activity is regulated in an adhesion-dependent manner and, through the overexpression of wild-type CdGAP and a GAP-deficient mutant, as well as RNA interference, is shown to be required for normal cell spreading, polarized lamellipodia formation, and cell migration. Introduction of an actopaxin mutant defective for CdGAP binding, or reduction of actopaxin by using RNAi, significantly attenuated these effects. Conclusions: We have established that CdGAP is an important regulator of integrin-induced Rho family signaling to the cytoskeleton and that its interaction with the focal-adhesion protein actopaxin is critical for the correct spatial and/or temporal regulation of CdGAP function. A complete understanding of the coordination of signaling events downstream of integrin engagement with the extracellular matrix will provide valuable insight into the regulation of cell migration during processes such as wound repair, development, and tumor cell metastasis.
Introduction
The Rho family of GTPases, including Cdc42, Rac, and RhoA, are critical regulators of cell morphology, signal transduction, and motility. As such, their activity impacts upon multiple physiologic processes, including chemotaxis, neurite outgrowth, and embryonic development [1] [2] [3] . Misregulation of their signaling cascades contributes to cell transformation and disease states such as the Wiskott-Aldrich and Aarskog syndromes [4, 5] . Many of their effects are achieved through modulation of the cellular cytoskeleton as a result of binding to, and subsequent activation of, downstream effectors such as the p21-activated kinase (PAK), the Wiskott-Aldrich syndrome protein (WASP) and Diaphanous-related formins [6] . The GTPases themselves are positively regulated by guanine nucleotide exchange factors (GEFs) that catalyze the exchange of GDP for GTP and negatively regulated by GTPase-activating proteins (GAPs) that stimulate the hydrolysis of GTP back to GDP. The localized activation of the individual Rho GTPases in time and space has been well documented, for instance following growth-factor stimulation, integrin activation during cell spreading, lamellipodia formation, or directed motility [7] [8] [9] . However, establishing which of the 69 GEFs and 80 potential Rho GAPs are utilized in response to a given stimulus and how they are themselves locally recruited and regulated requires further study [10, 11] .
One emerging mechanism by which cells may recruit and regulate the localized activity of GEFs and GAPs is through the utilization of scaffold or adaptor proteins that are enriched in focal complexes and adhesions [12] . Focal complexes/adhesions are macromolecular structures that are assembled at sites of integrin engagement with the extracellular matrix and serve as both a structural link to the actin cytoskeleton, necessary for traction during cell migration, and as signal transduction centers. Paxillin is one of the prototypical focal-adhesion scaffold proteins and contributes to the localized regulation of Rho family GTPase signaling at focal adhesions through the recruitment of the Cdc42 and Rac GEF PIX via interaction with the Arf GAPs GIT1 and GIT2 (PKL) [13] . These Arf GAPs also indirectly terminate Rac activity through inhibition of Arf6 [14] . Paxillin, when tyrosine phosphorylated, as occurs after integrin ligation, may also recruit the atypical Rac GEF DOCK180/ELMO/Crk complex to stimulate integrindependent Rac activation [15] .
Interestingly, another paxillin binding partner and scaffold protein, actopaxin (a-parvin), is emerging as a bipartite regulator of GTPase activity. Initial studies indicated that actopaxin recruitment to focal adhesions, via its interaction with paxillin, was necessary for normal cell spreading [16] . Subsequently, phosphorylation of the actopaxin amino terminus was shown to stimulate lamellipodia formation, an indication of elevated Rac signaling [17] . This phenotype can, in part, be explained by the ability of actopaxin and another parvin family member, affixin (b-parvin), to interact with PIX ( [18] and our unpublished observations). In addition, in this report we show that actopaxin further regulates the dynamic activity of Rho GTPases through the recruitment to focal *Correspondence: turnerce@upstate.edu adhesions of the Cdc42-and Rac-specific GAP CdGAP. Furthermore, we show that this GAP, which was previously reported to regulate growth-factor-induced lamellipodia formation [19] , also plays a significant role in integrin-dependent signaling to the cytoskeleton to regulate cell spreading and cell migration.
Results and Discussion

CdGAP Localizes to Focal Adhesions
Integrins perform an important role in regulating the activation of Rho GTPases [20, 21] . This suggests that the key GTPase regulatory proteins (i.e., GEFs and GAPs) may be localized and activated at sites of integrin ligation with the extracellular matrix (ECM). Indeed, the GEFs aPIX and bPIX and GAPs p122RhoGAP and RC-GAP72 have been reported to localize to focal adhesions [22] [23] [24] . Although CdGAP, a GAP for Rac and Cdc42, is enriched in ruffles after growth-factor stimulation, its distribution in spreading cells has not been evaluated [25] . Thus, we examined the subcellular localization of CdGAP in spreading U2OS osteosarcoma cells plated on collagen in the presence of serum. Live cells, cotransfected with GFP-CdGAP and RFP-actin, were imaged with total internal reflection fluorescence (TIRF) microscopy, and CdGAP was found to be concentrated at the ends of actin stress fibers ( Figures 1A  and 1B) . TIRF imaging provided clear localization of CdGAP to adhesions sites, whereas epifluorescence imaging of these same cells showed less distinct localization because of a sizable pool of cytoplasmic CdGAP (data not shown). In addition, GFP-CdGAP was cotransfected with DsRed-paxillin, and TIRF microscopy imaging of these cells confirmed that a pool of CdGAP is enriched with paxillin at focal adhesions ( Figure 1C) . GFP expressed as a control did not show an enrichment at focal-adhesion structures, indicating the specificity of the CdGAP localization (data not shown). The localization of CdGAP to focal adhesions was more prominent in spreading cells as compared to cells that had been plated for an extended time period, suggesting the localization may be dynamically regulated (data not shown). A similar localization of endogenous CdGAP was also observed (see Figure S1 in the Supplemental Data available online).
A Role for CdGAP GTPase Activity in Cell Spreading and Polarization For determining whether CdGAP activity was modulated in response to integrin ligation, GFP-CdGAP-expressing U2OS osteosarcoma cells were either held in suspension or spread on collagen for 15, 30, 60, or 150 min, a process that mimics signaling and morphologic changes occurring during the formation of lamellipodia at the leading edge of migrating cells [26] . The CdGAP was immunoprecipitated from cell lysates, and GAP assays were performed with GTP-loaded Rac as a substrate. The GAP activity of CdGAP was found to increase by up to 40% over the time course of integrin ligation, with significantly more activity at 60 and 150 min after adhesion than in suspension (Figure 2A ), suggesting a potential role in limiting lamellipodia extension.
To formally test whether CdGAP is involved in the regulation of integrin-mediated Rho GTPase signaling, we first generated a CdGAP mutant (R56AN169V) that, on the basis of homology with other GAPs, would be predicted to be GAP deficient [19, 27] . GAP assays were performed, and, indeed, this mutant exhibited a reduction in GAP activity of over 70% as compared to wildtype CdGAP ( Figure 2B ). Next, GFP, GFP-CdGAP, or GFP-CdGAP R56AN169V was expressed in U2OS cells to evaluate a causative role for CdGAP activity during cell spreading. Cells were placed in suspension for 60 min and replated on collagen I-coated coverslips for 15, 30, 60, and 120 min, then fixed and stained with rhodamine phalloidin to visualize F actin ( Figure 3A illustrates cells at 120 min). Quantitation of cell area revealed that wild-type CdGAP decreased spreading at all time points examined, whereas the GAP-deficient mutant facilitated spreading at early time points ( Figure 3B ). The increased spreading exhibited by the GFP-CdGAP R56AN169V-expressing cells indicates a specific role for CdGAP in integrin-dependent Rac signaling, because this construct should selectively disrupt processes involving only endogenous CdGAP activity, rather than that of the total cellular Cdc42/Rac GAP pool.
U2OS cells generally develop after their initial spreading a highly polarized crescent-like morphology that is indicative of their motile phenotype [28] . Interestingly, expression of wild-type CdGAP inhibited the cell's transition into a polarized phenotype at 120 min, as evidenced by the reduction in number of cells exhibiting a single dominant lamellipodia ( Figures 3A and 3C ). In contrast, the GAP-deficient GFP-CdGAP R56AN169V mutant increased the percentage of cells exhibiting multiple lamellipodia, consistent with the perturbation of localized, if not total, cellular Rac and Cdc42 activity (Figures 3A and 3C) . Notably, this phenotype is similar to that observed after perturbation of other focal-adhesion components that regulate adhesion-dependent Cdc42 and Rac activity. For example, deletion of the LD4 motif of Paxillin, which is the region involved in binding a protein complex containing the Cdc42/Rac GEF PIX, the ArfGAP PKL, and the p21-activated kinase [13] , disrupts Rac signaling and leads to multiple lamellipodia in CHO.K1 fibroblasts [29] .
Rac is an important mediator of cell spreading [30] . Therefore, to evaluate whether the impact of CdGAP on lamellipodia formation was the result of modulation of Rac activity, we performed GST-PBD pull-down assays on spreading cells expressing wild-type CdGAP or the GAP-deficient mutant. GFP-CdGAP-expressing cells exhibited a substantial reduction in the level of active Rac, whereas, interestingly, CdGAP R56AN169V-expressing cells had total active Rac levels comparable to GFP control cells at 30 min after spreading (Figure 3D) . Thus, the elevated spreading and multiple lamellipodia formation resulting from overexpression of the GAP-deficient CdGAP are most likely due to CdGAP-R56AN169V has a significant reduction of GAP activity as compared to wild-type CdGAP. Error bars represent standard deviation from four separate experiments. * indicates significantly more hydrolysis than GFP control, p < 0.001. Expression levels of constructs are illustrated by western blotting for GFP. a localized perturbation in Rac signaling and is consistent with the enrichment of CdGAP to focal adhesions. Furthermore, coexpression of active Rac with CdGAP was able to completely rescue spreading in these cells, reinforcing the idea that the spreading effects observed in Figure 3 are due to CdGAP's GAP activity, as opposed to any potential scaffold function (areas at 30 min in square microns: GFP, 1018; V12 Rac, 1695; CdGAP, 565; and CdGAP/V12 Rac, 1567).
CdGAP RNAi was then performed to evaluate the role of the endogenous protein in cell spreading. We were unable to deplete CdGAP expression levels in U2OS cells. However, HeLa cells proved to be an effective system because CdGAP was significantly depleted from these cells by up to 90% when either of two oligonucleotides to CdGAP was used ( Figure 4A ). CdGAP depletion increased cell spreading at 30 min after adhesion on both fibronectin and collagen in these cells (Figures 4B and 4C) (similar effects were seen with both oligos, data not shown). Identical results were also obtained with HEK-293 cells (data not shown). Notably, as with expression of the GAP-deficient construct ( Figure 3D ), there was no global increase in Rac activation levels after CdGAP RNAi ( Figure 4D ). These data reinforce (D) PBD assays were performed at 30 min after adhesion to determine the active Rac levels of U2OS cells transfected with the indicated constructs. CdGAP overexpression inhibits Rac activity, whereas this effect is lost with the GAP-deficient variant, CdGAP R56AN169V. the specific role of CdGAP in cell spreading and localized Rac activation. The results also indicate that CdGAP's role in cell spreading is conserved throughout different cell lines and on different matrices. It is interesting to speculate that localized CdGAP activity both may serve to facilitate cycling of Rac activity at the cell's leading edge, where focal adhesions are also actively turning over [31] , and may function in restricting lateral membrane extensions during cell polarization and motility and thereby complement the role of active Rho in this regard [32] .
CdGAP Interacts with Actopaxin
In view of its subcellular distribution, CdGAP was tested for its ability to bind focal-adhesion proteins, and an interaction with actopaxin was identified. Actopaxin is a 372 amino acid (aa) F-actin, integrin-linked kinase and paxillin binding focal-adhesion protein consisting of an amino-terminal segment containing serine phosphorylation sites (aa 1-95), a pair of calponin homology (CH) domains (aa 96-200 and 262-372), and a hinge region between the CH domains (aa 201-261) [16] . The association between CdGAP and actopaxin was first demonstrated with GST fusion binding assays ( Figure 5A ). U2OS cells were transfected with Myc-CdGAP and then subjected to binding assays with several GST-actopaxin fusion proteins to map the binding site within actopaxin for CdGAP. Myc-CdGAP was found to interact with full-length (aa 1-372) and amino-terminal segments (aa 1-95 and aa 1-222) of actopaxin, but not fusion proteins consisting of the actopaxin hinge region or carboxyl terminus ( Figure 5A ), thereby mapping the actopaxin site of interaction with CdGAP to the actopaxin amino terminus.
The short (90 kDa) form of CdGAP consists of three distinct domains, the amino-terminal GAP domain (aa 1-181), the central region (aa 182-515), and the carboxy-terminal proline-rich domain (aa 516-820) [25] . Full-length and truncation mutants of CdGAP were expressed in U2OS cells and tested for their ability to interact with GST-actopaxin. As shown in Figure 5B , GST-actopaxin precipitated CdGAP constructs consisting of the full-length protein (aa 1-820), the amino-terminal GAP domain with the central domain (aa 1-515), or the central domain with the carboxy-terminal proline-rich domain (aa 182-820) ( Figure 5B ). However, actopaxin did not bind the isolated amino-terminal GAP domain (aa 1-181), the central domain (aa 182-515), or the carboxy-terminal proline-rich domain (aa 516-820) ( Figure 5B ). Therefore, we conclude that actopaxin interacts with the central domain of CdGAP, but requires either the CdGAP amino or carboxyl terminus to be present, perhaps to stabilize the conformation of the central domain, as was previously reported for the intersectinCdGAP interaction [25] . Importantly, GST-actopaxin was also able to precipitate the GAP-deficient full-length CdGAP (R56AN169V) mutant ( Figure 5B ).
CdGAP was expressed in an in vitro transcription/ translation rabbit reticulocyte system and binding assays to GST-actopaxin fusion proteins were performed in order to evaluate whether the association between CdGAP and actopaxin was direct. Both full-length (aa 1-372) and amino-terminal (aa 1-95) GST-actopaxin constructs were found to precipitate the in vitro-synthesized CdGAP ( Figure 5C ). ILK was also synthesized as a specificity control, and bound full-length actopaxin but not the amino-terminal region, consistent with previous studies ( Figure 5C ) [33] . Finally, the ability of the endogenous forms of actopaxin and CdGAP to associate in vivo was confirmed by coimmunoprecipitation from U2OS cell lysates ( Figure 5D ). Notably, in U2OS and HeLa cells, only the short isoform (approximately 90 kDa and identical to the overexpressed isoform used in this study) of CdGAP is expressed, whereas the longer isoforms, which are enriched in brain and heart tissue, are not evident (data not shown) [34] .
The Actopaxin-CdGAP Interaction Is Required for Regulation of Normal Cell Spreading Because CdGAP was shown to regulate cell spreading and integrin-dependent morphology (Figures 3 and 4) , the importance of its interaction with actopaxin, a known regulator of integrin signaling [16, 17] , was examined in this context. RNAi knockdown of endogenous actopaxin increased spreading, consistent with the increased lamellipodia formation that has been previously reported ( Figures S2A and S2B ) [35] . Furthermore, reduced levels of actopaxin expression reversed the decreased spreading seen with overexpression of CdGAP, and they did not further enhance the increased spreading seen with overexpressed GAP-deficient CdGAP at 30 min after adhesion ( Figure S2B ). Overall, these results are consistent with a requirement for actopaxin binding in CdGAP effects on integrin-based cell spreading and further suggest that the increase in spreading observed after actopaxin knockdown is at least in part due to disruption of CdGAP signaling.
We next constructed an actopaxin mutant that was unable to bind CdGAP in order to more specifically test a role for this interaction in adhesion-dependent processes. GST fusion proteins consisting of full-length actopaxin with deletions in aa 1-95 were generated to further define the CdGAP binding site. A full-length actopaxin construct lacking aa 21-25 (actopaxin D21-25) failed to bind CdGAP, but retained normal binding to ILK ( Figure 6A ). Furthermore, an Xpress-actopaxin D21-25 construct was unable to precipitate MycCdGAP when coexpressed in U2OS cells, but still bound ILK as effectively as the wild-type protein ( Figure 6B ). The Xpress-actopaxin D21-25 was then evaluated for its ability to affect the rate of cell spreading. Expression of actopaxin D21-25 in U2OS cells significantly increased spreading at 15 and 30 min after adhesion to collagen ( Figure 6C ), whereas wild-type actopaxin was without significant effect, as previously reported (Figure 6C) [17] . The increased spreading in cells expressing actopaxin D21-25 is consistent with perturbation of endogenous CdGAP signaling.
For determining whether CdGAP requires an interaction with actopaxin to exert its inhibitory effect on cell (B) GST-actopaxin binding assays were performed with cell lysates from U2OS cells transfected with the indicated CdGAP constructs. Actopaxin precipitated full-length CdGAP (aa 1-820), the full-length GAP-deficient mutant (aa 1-820 R56AN169V), an aa 182-820, or an aa 1-515 construct. Conversely, GST-actopaxin does not bind CdGAP aa 1-181, aa 182-515, or aa 516-820 constructs. (C) CdGAP and ILK were synthesized as 35 Slabeled proteins by using an in vitro transcription/translation rabbit reticulocyte system and used in binding assays with GST, GSTactopaxin 1-372, or GST-actopaxin 1-95. Results demonstrate that the association between actopaxin and CdGAP is direct and occurs within the amino-terminal 95 amino acids of actopaxin. ILK was used as a specificity control because it binds to the actopaxin carboxyl terminus. (D) Endogenous actopaxin was precipitated from asynchronously growing U2OS cells. The lysate lane contained 20 mg protein, and immunoprecipitations were performed from 250 mg each. Endogenous CdGAP coprecipitated with actopaxin, and a-actinin served as a negative control. The control immunoprecipitation was performed with nonspecific Rabbit IgG. Approximately 10% of available actopaxin was precipitated, and 1% of endogenous CdGAP was coprecipitated.
spreading, actopaxin constructs were coexpressed with CdGAP, and the transfected cells were allowed to respread on collagen. Coexpression of actopaxin D21-25 with CdGAP significantly reversed the impaired spreading that resulted from overexpression of CdGAP alone ( Figure 6D ). In contrast, a phospho-mimetic S4/ 8D actopaxin mutant that has previously been shown to promote cell spreading [17] , and which binds CdGAP as effectively as wild-type actopaxin (data not shown), failed to rescue the CdGAP inhibition of spreading, thus reinforcing the specificity of the rescue seen with actopaxin D21-25 ( Figure 6D ). These results indicate a specific requirement for actopaxin binding in CdGAP signaling, whereas the failure of the actopaxin phospho-mimetic S4/8D mutant to revert the reduced spreading caused by CdGAP overexpression is consistent with the previously reported role for actopaxin phosphorylation in facilitating the localized function of Rac effectors [17] .
A role for actopaxin in regulation of adhesion-dependent CdGAP signaling was most likely due to either regulation of CdGAP's enzymatic activity or focal-adhesion
targeting. An evaluation of GAP activity during spreading was performed with cells that had been transfected with the GAP and control vector, wild-type actopaxin, or actopaxin D21-25. CdGAP's activation during spreading was equivalent under each condition, indicating that actopaxin binding does not control activity of CdGAP (data not shown). Similarly, the inclusion of actopaxin fusion protein in CdGAP in vitro GAP activity assays indicated that the interaction between these proteins does not directly affect the GAP activity of CdGAP (data not shown). For evaluating the possibility that actopaxin regulates CdGAP localization to focal adhesions, cytoskeletal fractionation experiments were performed with asynchronously growing cells versus cells plated on collagen for 1 hr to determine the amount of CdGAP localized in the cytoskeletal/focal-adhesion fraction [36] . In cells expressing Myc-tagged CdGAP and either empty vector (EV) or wild-type actopaxin, there was an increase in the amount of CdGAP in the cytoskeletal fraction at 60 min after adhesion as opposed to cells growing asynchronously in culture ( Figure 7A ). This increased targeting to the cytoskeleton was lost when the actopaxin D21-25 mutant was coexpressed with CdGAP ( Figure 7A ). In agreement with this result, expression of actopaxin D21-25 significantly disrupted the focal-adhesion localization of CdGAP in spreading cells as quantified by TIRF microscopy ( Figure 7B ). These results indicate that expression of an actopaxin mutant (D21-25) that can target to focal adhesions (data not shown), but that lacks the capacity to bind CdGAP, diminishes the ability of overexpressed CdGAP to regulate cell morphology through inhibition of CdGAP's recruitment to, or stabilization in, the focal adhesion/cytoskeletal fraction. Further, the inability of actopaxin D21-25 to affect the adhesion-dependent GAP activity of CdGAP indicates that activation of this GAP may occur before its targeting to adhesion sites. Alternatively, the results presented herein may indicate that actopaxin binding serves to stabilize CdGAP at adhesion sites with the GAP's localization being only transient when its association with actopaxin is disrupted. This scenario would allow for CdGAP to become activated during adhesion as a result of its focal-adhesion localization. A mutant of CdGAP unable to bind actopaxin would have to be developed to definitively test this possibility.
CdGAP Mediates Random Motility
Our results demonstrate that overexpression of CdGAP inhibits the formation of lamellipodial extensions occurring during cell spreading and polarization. Because the morphologic events that a cell undergoes during spreading closely mimic those that occur at the leading edge of migrating cells [26] , we evaluated CdGAP's ability to modulate motility by using Modified Boyden chamber assays. Interestingly, CdGAP was found to inhibit random motility ( Figure 7C ). Furthermore, expression of actopaxin D21-25 marginally increased the percentage of migrating cells, whereas wild-type actopaxin was without effect, thereby suggesting a role for actopaxin binding to endogenous CdGAP in regulation of random motility ( Figure 7C ). This was confirmed by coexpression of actopaxin D21-25 with CdGAP, a condition that alleviated the decreased motility observed with overexpression of the GAP alone ( Figure 7C ). In contrast, and as observed with spreading experiments, the S4/8D actopaxin mutant, which increased random motility when expressed alone, was unable to revert the CdGAP phenotype ( Figure 7C ).
The precise temporal and spatial regulation of the Rho family of small GTPases plays a critical role in controlling the cytoskeletal and adhesion changes that are necessary for productive cell migration [6] . For instance, it is well established that activation of Cdc42 and Rac at the front of the cell coordinates filopodia and lamellipodia extension, whereas activation of Rho is necessary for the generation of contractile forces and tail retraction [6] . In the current study, CdGAP is identified as an important negative regulator of integrin-mediated Rac activity. We show that CdGAP is recruited to focal adhesions, and consistent with this localization, its GAP activity is stimulated toward the later stages of integrin-dependent spreading. This time course of CdGAP activation is in agreement with a role for this protein in reducing the level of integrin-stimulated Rac activity as the cell transitions from a spreading to a more polarized motile phenotype [30] .
Importantly, herein we identify the focal-adhesion protein actopaxin as a direct binding partner for CdGAP and show that expression of an actopaxin mutant lacking the CdGAP binding site prevents CdGAP-dependent inhibition of cell spreading and cell migration. These observations, in addition to the ability of the GAP-dead mutant to induce cell spreading and the formation of multiple lamellipodia while having little effect on global Rac activity, emphasizes the importance of subcellular compartmentalization in facilitating CdGAP function. Interestingly, we have also observed that actopaxin binds to the PIX family of Rac/Cdc42 GEFs (unpublished observation, D.P.L., D.M. Clarke, S.E. Hetey, and C.E.T.), as is the case with affixin, another member of the actopaxin/parvin family [18] . This interaction possibly contributes to the ability of PIX to stimulate cell spreading [37] and cell polarization [38] , and may also explain how actopaxin phosphorylation promotes lamellipodia formation and cell migration [17] . Whether actopaxin functions primarily to control the subcellular localization of CdGAP and PIX, or is also involved directly or indirectly in regulating their enzymatic activity, remains to be fully determined. Regardless, actopaxin interacts with both positive and negative regulators of Rac and Cdc42 signaling, a role shared by another actopaxin binding partner, paxillin. This focal-adhesion scaffold protein binds various GEFs and GAPs, including PKL (an Arf GAP that negatively regulates Rac signaling), p190RhoGAP, and PIX, and has also been implicated in the spatial and temporal control of Rho GTPase signaling [12] . A module composed of both actopaxin and paxillin may constitute a multifunctional hub for the regulation of p21 GTPase signaling at the plasma membrane, a hub that serves to fine-tune the cell's response to external stimuli. This signaling nexus may not only be important in the control of adhesion signaling in single motile cells as demonstrated in this report, but could also constitute an important center of integrin-cytoskeleton regulation in muscle tissues. In that context, actopaxin has previously been shown to perform an evolutionarily conserved structural role via interactions with integrin-linked kinase and PINCH [39] [40] [41] . Our recent findings suggest that it may additionally function in the control of Rho GTPase signaling associated with the cytoskeleton remodeling that occurs during muscle contraction [42] [43] [44] .
Conclusions
The specific GAPs and GEFs that spatially and temporally control Cdc42 and Rac activity during integrin-mediated cell spreading and motility are still poorly defined. We have identified the Cdc42/Rac GAP CdGAP as an important negative regulator of adhesion-dependent signaling and demonstrate that the effects of CdGAP are dependent upon its direct association with the focal-adhesion scaffolding protein actopaxin.
Experimental Procedures Antibodies and Materials
Rabbit polyclonal antibodies to GFP were purchased from Molecular Probes and Santa Cruz Biotechnologies. Polyclonal antibody to actopaxin and monoclonal antibody to a-actinin were obtained from Sigma-Aldrich. Monoclonal antibodies to paxillin, ILK, and Rac were obtained from BD Transduction laboratories. The Omniprobe polyclonal antibody was purchased from Santa Cruz Biotechnologies. Polyclonal antibody against the CdGAP proline-rich domain was as previously described [34] . The 9E10 anti-Myc monoclonal antibody developed by J.M. Bishop was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences (Iowa City, Iowa 52242). Purified collagen type 1 was purchased from Cohesion.
Plasmids
Xpress-actopaxin D21-25 and GFP-CdGAP R56AN169V constructs were generated by QuickChange mutagenesis (Stratagene) and sequenced in their entirety at the SUNY Upstate DNA Core Facility. Actopaxin and CdGAP truncation constructs were as previously described or generated by PCR reactions [16, 17, 25, 45] . GST-PBD and GST-Rac1 were provided by Richard Cerione (Cornell University, Ithaca, New York). Rac V12 was provided by Mark Symons (Institute for Medical Research at North Shore-LIJ, Manhasset, New York). Paxillin-DsRed was provided by Rick Horwitz (University of Virginia, Charlottesville, Virginia), and RFP-actin was provided by Klemens Rottner (German Research Centre for Biotechnology, Braunschweig, Germany).
Cell Spreading, Immunofluorescence, and Morphological Analysis Cells were placed in suspension and spread on collagen for times as indicated and areas quantified as previously described [17, 46] . Standard epifluorescent microscopy imaging was performed with a Zeiss Axioskop 2 Plus microscope equipped with a SPOT RT slider camera (Diagnostic Instruments). TIRF microscopy was performed on a NIKON Eclipse TE-2000 U inverted microscope equipped with a 603 TIRF objective (CFI Plan/Apo TIRF 603/1.45; Nikon) and fiber-optic-coupled laser illumination. Cells were cultivated on collagen-coated 35 mm glass-bottomed dishes (MatTek corporation, Ashland, Massachusetts) and kept at 37ºC in a heating chamber (model TC-202A, Harvard Apparatus, Holliston, Massachusetts). Fluorescence was excited either by an argon ion laser (488 nm) or a HeNe laser (543 nm) and passed through emisson filters optimized for GFP or TRITC (Chroma Technology, Rockingham, Vermont). Images were acquired with a cooled CCD camera (Hamamatsu Orca II, ERG) and processed with SimplePCI software. For evaluation of actopaxin-dependant CdGAP localization to focal adhesions, TIRF images were taken of spreading cells that had been cotransfected with DsRed-paxillin and GFP-CdGAP. CdGAP was considered localized to focal adhesions if it displayed localization to paxillin containing structures and its pixel intensity at adhesions was at least 2.5 times that of the nonlocalized pool's pixel intensity.
Cytoskeletal Fractionation
Fractionation of soluble and cytoskeletal fractions was performed essentially as previously described [36] . Asynchronously growing cells or cells adherent to 10 mg/ml collagen for 60 min were lysed in cytoskeletal stabilization buffer (25 mM PIPES, pH 7.2, 0.3 M Sucrose, 0.5% Triton X-100, 100 mM KCl, 1mM CaCl 2 , 2.5 mM MgCl 2 , 200 mM Na 3 VO 4 , 2 mM NaF, 10 mg/ml leupeptin, 1 mM PMSF) for 3 min on ice. The supernatant was collected and constituted the soluble fraction. The residual cellular components constituted the cytoskeletal component.
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